Brand Name | Status | Last Update |
---|---|---|
acetazolamide | ANDA | 2024-02-05 |
acetazolamide extended-release | ANDA | 2024-01-09 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
altitude sickness | EFO_1000782 | D000532 | T70.29 |
glaucoma | EFO_0000516 | D005901 | H40 |
seizures | HP_0007359 | D012640 | G40.4 |
Code | Description |
---|---|
J1120 | Injection, acetazolamide sodium, up to 500 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Altitude sickness | D000532 | EFO_1000782 | T70.29 | 4 | 2 | 3 | 12 | 2 | 22 |
Obstructive sleep apnea | D020181 | EFO_0003918 | G47.33 | 3 | 9 | 1 | 4 | 1 | 15 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | 3 | 9 | — | 12 |
Heart failure | D006333 | HP_0001635 | I50 | — | — | 4 | 5 | 1 | 10 |
Sleep apnea syndromes | D012891 | HP_0010535 | G47.3 | 1 | 3 | — | 2 | 2 | 7 |
Glaucoma | D005901 | EFO_0000516 | H40 | — | — | 1 | 3 | 1 | 5 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | 3 | 2 | 1 | — | 4 |
Central sleep apnea | D020182 | — | G47.31 | — | 1 | 1 | 1 | — | 3 |
Alkalosis | D000471 | HP_0001948 | E87.3 | — | — | 1 | 1 | 1 | 3 |
Pulmonary edema | D011654 | EFO_1001134 | J81 | — | — | — | 1 | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pseudotumor cerebri | D011559 | EFO_1001132 | G93.2 | 1 | 1 | 3 | — | — | 4 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 2 | 1 | — | 1 | 4 |
Retinal artery occlusion | D015356 | EFO_1001154 | H34.1 | — | — | 1 | — | — | 1 |
Hemodilution | D006438 | — | — | — | — | 1 | — | — | 1 |
Visual acuity | D014792 | — | — | — | — | 1 | — | — | 1 |
Fibrinolysis | D005342 | — | — | — | — | 1 | — | — | 1 |
Neurocysticercosis | D020019 | — | — | — | 1 | 1 | — | — | 1 |
Intracranial thrombosis | D020767 | — | — | — | — | 1 | — | — | 1 |
Status epilepticus | D013226 | EFO_0008526 | G41 | — | 1 | 1 | — | — | 1 |
Landau-kleffner syndrome | D018887 | EFO_1001010 | G40.8 | — | 1 | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Macular edema | D008269 | — | — | — | 3 | — | — | — | 3 |
Chronic pain | D059350 | HP_0012532 | — | — | 2 | — | — | — | 2 |
Macular degeneration | D008268 | EFO_0001365 | H35.30 | — | 2 | — | — | — | 2 |
Diabetic retinopathy | D003930 | EFO_0003770 | — | — | 2 | — | — | — | 2 |
Brain edema | D001929 | EFO_1000845 | G93.6 | — | 1 | — | — | 1 | 2 |
Cerebrospinal fluid leak | D065634 | — | G96.0 | — | 2 | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | — | 2 |
Melanoma | D008545 | — | — | 2 | 1 | — | — | — | 2 |
Retinal dystrophies | D058499 | HP_0000556 | — | — | 1 | — | — | — | 1 |
Compliance | D003187 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | 2 | 3 |
Pure autonomic failure | D054970 | — | — | 1 | — | — | — | — | 1 |
Orthostatic hypotension | D007024 | — | I95.1 | 1 | — | — | — | — | 1 |
Glioma | D005910 | EFO_0000520 | — | 1 | — | — | — | — | 1 |
Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
Cognition | D003071 | EFO_0003925 | — | 1 | — | — | — | — | 1 |
Small cell lung carcinoma | D055752 | — | — | 1 | — | — | — | — | 1 |
Cocaine-related disorders | D019970 | — | F14 | 1 | — | — | — | — | 1 |
Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
Andersen syndrome | D050030 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sickle cell anemia | D000755 | EFO_0000697 | D57 | — | — | — | — | 2 | 2 |
Migraine disorders | D008881 | EFO_0003821 | G43 | — | — | — | — | 2 | 2 |
Thalassemia | D013789 | EFO_1001996 | D56 | — | — | — | — | 1 | 1 |
Kidney calculi | D007669 | EFO_0004253 | N20 | — | — | — | — | 1 | 1 |
Ischemic stroke | D000083242 | — | — | — | — | — | — | 1 | 1 |
Bartter syndrome | D001477 | Orphanet_112 | E26.81 | — | — | — | — | 1 | 1 |
Intracranial hypertension | D019586 | EFO_1000992 | — | — | — | — | — | 1 | 1 |
Angle-closure glaucoma | D015812 | — | — | — | — | — | — | 1 | 1 |
Headache | D006261 | HP_0002315 | R51 | — | — | — | — | 1 | 1 |
Ventilator weaning | D015300 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Acetazolamide |
INN | acetazolamide |
Description | Acetazolamide is a sulfonamide, a member of thiadiazoles and a monocarboxylic acid amide. It has a role as a diuretic, an anticonvulsant and an EC 4.2.1.1 (carbonic anhydrase) inhibitor. It is a conjugate acid of an acetazolamide(1-). It derives from a hydride of a 1,3,4-thiadiazole. |
Classification | Small molecule |
Drug class | carbonic anhydrase inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)Nc1nnc(S(N)(=O)=O)s1 |
PDB | — |
CAS-ID | 59-66-5 |
RxCUI | — |
ChEMBL ID | CHEMBL20 |
ChEBI ID | 27690 |
PubChem CID | 1986 |
DrugBank | DB00819 |
UNII ID | O3FX965V0I (ChemIDplus, GSRS) |